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Abstract 
This study aimed to assess the status of cell mediated immunity for pulmonary tuberculosis patients 
through evaluation levels of Interleukins (IFN-γ ,IL-10, IL-12) and estimation vitamin D3 . Whole blood 
samples collected from 50 pulmonary tuberculosis patients who are admitted to consultant clinic for respiratory 
diseases in Hilla – Babylon province during the period from February 2016 to February 2017. Out of the pTB 
patients, there were 27 males and 23 females, the patients age range was between 12-80 years. Cytokines levels 
and vitamin D3 estimated by using ELISA technique. The mean of serum concentration of IL-10  and IL-12 
revealed that there is a significantly increased (p˂ 0.05) in pulmonary tuberculosis patients as compared to 
controls (4.024 and 1.049)pg/ml (51.563 and 13.514) pg/ml ,respectively. While, the mean of serum 
concentration of IFN-γ showed no significant increasing (p˃0.05) in pulmonary tuberculosis patients compared 
to controls (36.505 and 25.019)pg/ml.  The mean of serum concentration of VD3 showed a significant 
decreasing (p˂ 0.05) in pulmonary tuberculosis patients as compared to controls (18.186 and 29.321) ng/ml.  
Conclusions: 
The results provide a good correlation between the levels of  IL-10 , IL-12, IFN-γ and Vitamin D3 with 
the cellular immunity against pulmonary tuberculosis.  
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Introduction 
Tuberculosis (TB) is a poverty disease that thrives where economic and social 
determinants of ill health prevail, as well as that mostly affects in young adults in their most 
productive years living in the developing world [1]. About one-third of the world’s 
population estimated to have been exposed to bacteria of TB and infected potentially [2]. Of 
those infected, only a little proportion will become sick with TB [3] nevertheless people 
living with HIV, people with weakened immune systems caused by the prolonged use of 
medicines such as TNF-α inhibitors or steroids , and diabetes patients, silicosis, and    renal 
insufficiency have a much greater risk of falling ill from TB [4]. Infection with 
Mycobacterium tuberculosis results in a variety of conditions which ranging from 
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asymptomatic infection to active tuberculosis with pulmonary or extrapulmonary 
involvement. In most cases, MT infection has no been fatal.  A variety of clinical features of 
TB results from cell-cell interactions that promoted by cytokines produced by immune cells 
during response to MT infection [5]. On the way to prevent tissue damage, active  
tuberculosis is related to decreased Th1 and increased production and action of suppressing 
cytokines generated by Th2   cells,  which act by deactivating macrophages, modulating 
proinflammatory cytokines, and reducing the function of T cells for antigen presenting [6].  
IL-12 is a vital cytokine in the host defense against mycobacterial infections.  Additionally, 
IL-12 favors development of T helper 1 responses by enhancing IFN-γ [7]. IFN-γ is the 
major cytokine of Th-1 cells, therefore, as proinflammatory immune response, it protects 
against MTB. IFN-γ activates macrophages for kill intracellular mycobacteria [8]. IL-10 
inhibits production of IFN-γ and antigen specific T helper 1 proliferation responses, up-
regulates T helper 2 responses and prevents activation of macrophage [7]. Deficiency of 
vitamin D has implicated as a risk factor for tuberculosis [9]. The important role for vitamin 
D in modulation of the innate immune via its role is an immunomodulator [10]. 1,25-
dihydroxy vitamin D3[1,25(OH)2D3]is the active metabolite  form of vitamin D, which 
modulate  immune function  mediated  macrophages,  monocytes,  dendritic cells, T and B 
cells.  A recent study demonstrated that vitamin D supplementation restored the impaired    
immune response with better clinical outcome in TB patients, which reveals that sufficient 
levels of vitamin D has an important role to control the intracellular infection such as 
tuberculosis [11].  
 
Materials  
Population of the study-included patients with pulmonary tuberculosis (pTB) 
admitted to consultant clinic for respiratory diseases in Hilla – Babylon province during the 
period from February 2016 to February 2017. Out of the pTB patients, there were 27 males 
and 23 females, the patients age range was 12-80 years.  Exclusion Criteria: Any patients 
with DM, malignancy, allergic and pregnant women excluded from this study. In addition to 
fifty apparently healthy control groups who had no history of pulmonary Tuberculosis.  
 
Collection of Samples  
The serum   separated for serological studies; 3 ml of the blood sample allowed to clot for 
about 15 min. at room temperature, then loosed the clot gently from a wall of the tube by means of a 
wooden stick. After that, the sample centrifuged for 10 min at about 2500 rpm and finally the serum 
transferred to another tube for storage at - 20°C. 
 
Methods 
ELISA (Enzyme linked immunosorbent assay) Test 
Measurement of IL-10, IL-12, IFN-γ and vitamin D3. These parameters estimated by 
ELISA technique according to the instruction of manufacture company (Elabscince-China).  
Statistical Analysis: The statistical package for the Social sciences version 18 (SPSS Inc., 
Chicago, USA) used for statistical analysis. This study used statistical analysis that included 
calculation of mean values and percentage. The data were analyzed with a chi-square and t-
student tests, and the level of significance was set at p<0.05 [12]. 






Results and Discussions 
1- Estimation of IL-10 in Serum of Studied Groups 
The mean of IL-10 concentration in pulmonary TB (pTB) patients sera (4.024) pg/ml, 
while in control groups (1.049) pg/ml. The study significantly shows  the difference between 
pTB and controls, (p<0.05), Table (1). The study shows IL-10 was significantly higher in 
pulmonary TB than in controls.  
This finding was matched approximately with [13] who mentioned that active pTB 
patients had higher levels of anti-inflammatory cytokines IL-10 (P < 0.001) Compared to 
healthy subjects. This finding also matched with [14] who found that the levels of IL-10 in 
pulmonary tuberculosis group were significantly higher than the control group. 
 
Table (1) IL-10 Concentration in serum of studying groups 
P value Range Mean ( pg/ml)+ SD Study groups 
0.0002* 
1.28-7.07 4.024±1.459 Patients 
0.01-2.37 1.049±0.56 Controls 
*= Significant (P≤ 0.05)                                                          
 
 [15] who found that significantly raised serum levels of IL-10 in patients with active 
pTB. The blocking action of IL-10 in vivo during chronic infection stabilized the pulmonary 
bacterial load and improved the survival. Furthermore, this beneficial outcome was 
extremely associated with the recruitment of T cells to the lungs and was enhanced T cell 
IFN-γ production. The results indicated that IL-10 promotes progression of Tuberculosis 
disease. These findings have important diagnostic and/or the therapeutic implications for 
prevention of reactivation Tuberculosis in humans [16]. The blocking of IL-10 in 
Mycobacterium tuberculosis (Mtb) infected macrophages, allows phagosome maturation, but 
the addition of IL-10 to cells infected with killed Mtb successfully inhibits its maturation, 
resulting in enhanced survival of Mtb via inhibiting phagosome maturation by IL-10 [17].  It 
predicted that production of low level of IL-10 by activated macrophages was required for an 
efficient antimicrobial response, control of bacterial growth and for prevent damage of the 
lung. Consequently, modulation of IL-10 levels through TB therapy might shorten duration 
of the treatment and accelerate the bacterial clearance [18].  Other studies found that IL-10 
has shown to be elevated in the lungs and serum of active PTB patients. The production of 
IL-10 following  Mtb  phagocytosis  by macrophages may   happen as a natural antimicrobial 
response via the host, otherwise may be induced by the bacteria as mechanism of evasion . 
IL-10 block maturation of  the phagosome, which facilitates survival and outgrowth of Mtb 
[19].  In human tuberculosis, IL-10 production is higher in anergic patients, suggesting that 
M. tuberculosis induces IL-10 production, suppressing an effective immune response. In 
populations of some human, an increase in IL-10 expression identified, being possible to 






correlate it with an inefficiency in vaccination with BCG (Bacillus Calmette-Guérin). The 
analysis of IL-10 gene polymorphisms involved in the development of infectious diseases 
suggests that this polymorphism has a critical role in the immunity and progression of 
inflammation. The increase production of IL-10 can, in particular, suppress the immune 
response and promote the disease progression [20]. A study in Gambia investigated that 
NRAMP1 influenced TB susceptibility by regulation of IL-10. Higher levels of IL-10 could 
lead to TB development through two different mechanisms:(a) IL-10 control TB infection 
through up-regulation of macrophage and production compounds of microbicidal. (b) IL-10 
regulates development of secondary immune response in tuberculosis. Depended on the 
reported results, manipulation of the IL-10 pathway may be a novel immunotherapy for 
treatment of tuberculosis in the future [21]. 
2- Estimation of IL-12 in Serum of Studied Groups 
The mean of IL-12 concentration in pulmonary TB patients, sera was (51.563)pg/ml, 
while in control groups was (13.514) pg/ml. The study significantly shows the difference 
between pTB and controls, (p< 0.05); Table (2). The study shows IL-12 was significantly 
higher in pulmonary TB than in control groups. The result matched approximately with [22] 
who showed that the samples from patients infected with Mycobacterium tuberculosis was 
significantly higher levels of IL-12, (p< 0.05).  
                     Table (2) IL-12 Concentration in Serum of Patients and Controls 
P value Range Mean (pg/ml) ± SD Study groups 
0.007* 
12.36- 436.64 51.563±20.485 Patients 
2.87- 43.74 13.514±5.051 Controls 
*= Significant (P≤ 0.05)                                                          
 
Another study found significantly increased level of circulating IL-12 in extensive 
disease, (241.6±104.6 pg/ml); when compared to minimal (80.7± 21.4 pg/ml) according to 
the radiographic extent of lung lesions in  pTB patients, but found  in active pTB patients, 
serum IL-12 concentrations were lower than in healthy controls [23]. [24] found that serum 
concentration of IL-12p-70   in active TB patients and MDR-TB elevated than in patients 
after anti-TB treatment, and mentioned that measuring levels of several cytokines in the 
serum may useful for evaluating the activity of TB disease and monitoring the clinical effects 
of anti-tubercular treatment. During Mycobacterium tuberculosis infection, IL-12p70 level 
was elevated due to activation of macrophages upon a successful interaction of the toll-like 
receptors (TLRs) present in the phagosome and cell surfaces with the Mtb-associated 
antigens[25].  While the study of [26] was found that the average level of serum IL-12 in 80 
pulmonary TB patients  was significantly lower than   in  the healthy control group. Studying 
of [27] showed that supplying   IL-12 and neutralizing IL-27 enhanced acidification and 
fusion of mycobacterial-containing phagosomes with lysosomes. In addition, cathepsin D 
was associated with the bacteria and matured to the active form when IL-12 supplied and IL-






27 neutralized. Lysosomal acidification and cathepsin D activity were associated with control 
of mycobacteria. Lysosomal acidification, association with mycobacteria, and maturation of 
cathepsin D required IFN-γ production from macrophage. IL-12 is essential for the 
generation of a protective immune response to M. tuberculosis, with its main functions being 
induction of expression of IFN-γ and activation of antigen-specific lymphocytes capable of 
creating a protective granuloma. Patients with defective receptors for IL-12 were highly 
susceptible to severe mycobacterial infections.  
3-Estimation of IFN-γ in Serum of Studied Groups 
The mean level of interferon gamma (IFN-γ) concentration in the serum was (36.505) 
pg/ml for pulmonary TB patients and 25.019) ) pg/ml in health groups.Table (3) shows 
interferon gamma IFN-γ concentration no significant difference between pTB patients and 
controls, (p> 0.05). The study found no significant raised serum levels of IFN-γ in patients 
with pulmonary TB. This finding matched approximately with previous studies [28] who 
found that the levels of IFN-γ in pulmonary tuberculosis group were no significantly higher 
than control group (0.123 IU/ml, p> 0.05).  This means that pTB patients involved in this 
study have a low level of IFN-γ that inadequate to be capable to activate   the 
mycobactericidal activity of alveolar macrophages and results in  the reduction of cell 
mediate immunity for pulmonary TB patients. Depending on the fact that represent a 
cytokine regulator of CMI increases dramatically   at least 10 fold greater than the 
concentration in normal state in which there is no an antigenic stimulation [29].  
            Table (3) IFN-γ Concentration in serum of studying groups    
P value Range Mean (pg/mL) ± SD Study groups 
0.132* 
16.93- 49.52 36.505±16.509 Patients 
11.41-59.93 25.019±11.339 Controls 
*=  No significant (P > 0.05)                                                         
 
This may because most of clinically diagnosed TB patients on antituberculosis 
treatment and, therefore, the healing effect on granuloma could reduce the number of local 
and circulating IFN-γ-producing activated T-cells. Investigators were reported increased 
levels of IFN-γ in the sputum or pleural effusion and observed a correlation between IFN-γ 
and disease activity in some studies. IFN-γ produced by a variety of cells involved in the 
immune response against Mtb. Th1 cells that produce gamma interferon IFN-γ confer 
resistance to infection with mycobacteria. At the site of infection with Mtb, it is the major 
cytokine of type 1 T helper (Th1) cells, therefore, as it protects against Mtb [24]. [30] who 
mentioned that serum IFN-gamma level was not found statistically significant (p= 0.4) in the 
differential diagnosis of active and inactive pulmonary tuberculosis. While study of [31] who 
found that the levels of IFN-γ in pulmonary tuberculosis group were significantly higher than 
control group (P<0.01 or P<0.05). In study of [32],who mentioned that count of T cell was 
decreased significantly for TB patients in study carried out in Babylon province. TGF-β 






mediated regulatory mechanisms that down modulated responses of Th1during active TB in 
human, CD4+ CD25+ T cells   reported to be present at elevated level in TB as well as to be 
able to depress T-cell-mediated IFN-γ production in patients with TB. The study of [28] 
indicated the persistence of measles infection as one inhibitory mechanism for cell mediated 
immunity against TB infection. Therefore, infection with measles virus leads to immune 
suppression resulting in decreased CMI, and at the same time, increased susceptibility to TB 
infection for the duration of immune suppression. [33] who mentioned that most TB patients 
in Babylon province/Iraq were affected by immune anergy. Numerous predisposing factors 
increased frequency of immune anergy including viral infections in addition to metabolic 
disorders especially renal failure and diabetes mellitus. Results of no increasing Th1 cytokine 
profile in TB patients were indicated   presence of reducing cell mediated of TB patients in 
spite of mycobacterial antigens presence. This unresponsiveness reflect  the inhibitory signals 
for cell- mediated immunity induced by CMV which was considered as on viruses with 
potential activity for inducing immune anergy.  The study of [34] were found that the level of   
IFN-γ significantly (P = 0.001) changed and the sputum smear conversion was significantly 
earlier in the zinc and vitamin A supplemented group. There is in vitro facts that TB patients 
with progressive disease fail to generate IFN-γ in response to stimulation with mycobacterial 
antigens.  
4- Estimation of VD3 in serum of studied groups 
The mean of VD3 concentration in pulmonary TB patients sera was (18.186) ng/ml, 
while in control groups was (29.321) ng/ml. The study significantly shows the difference 
between pTB and controls, (p< 0.05), Table (4). The study shows VD3 was significantly 
lower in pulmonary TB than controls. This finding matched approximately with [9]who 
mentioned that patients with pulmonary tuberculosis was significantly  deficient of Vitamin 
D when found the mean ±SD serum level of 25-hydroxyvitamin D3 in pTB and control 
groups were 27.1±9.7 and 36.8±8.1 respectively (p=0.0001). This finding also matched with 
[10] who showed that the concentrations of VD3 in pTB patients lower than the healthy 
adults. 
Table (4) Vitamin D3 Concentration in serum of Patients and Controls  
P value Range Mean  (ng/ml) ± SD Study groups 
0.0007* 
2.60-25.90 18.186±5.019 Patients 
16.81-89.4 29.321±7.700 Controls 
*= Significant (P≤ 0.05)                                                          
      
The reason for low level of VD3 in the serum in pTB could be reflect increased 
utilization of VD or reflect lower exposure to the sun [35] or possibilities that result from 
tuberculosis itself [9] . Low levels of vitamin D in the serum may also be associated with 
poor nutritional status in patients with TB [36]. In a cohort follow-up study from Pakistan, 
low levels of vitamin D were associated with progression to active TB disease in healthy 






household contacts. The findings suggested as well the higher susceptibility of women to the 
infection, due to their poor nutrition, low socioeconomic status,  traditional/cultural traits, 
and little exposure to sunlight [37]. Vitamin D3 is important for the host resistance to TB; 
pulmonary TB patients with deficiency of VD3 was not able to mount adequate control of 
primary Mtb infection in the lungs. Additional, VD3 has implicated in the immunological 
control of TB in humans involving the orchestration of IFN-γ, IL-15 and IL-32 signaling. A 
recent evaluation of therapeutic potential of VD3 in combination with PBA has shown an 
improved effects of anti-mycobacterial and faster the conversion to AFB-negative sputum by   
participating TB patients. In vitro the evaluation of Mtb-infected macrophages treated with 
VD3 lead to upregulation of a collage of anti-inflammatory (IL-10, ARG1) and genes of pro-
inflammatory (IL1B, TNF) over a 72-hour exposure period. In endemic countries, the 
therapeutic potential of VD3 in patients with MDR-TB therefore warrant further clinical 
evaluation in larger cohorts of TB patients [38]. [39] who mentioned that high doses of 
vitamin D were widely used to treat tuberculosis patients in the preantibiotic era. This 
approach was successful: vitamin D could suppress growth of intracellular of M tuberculosis 
in vitro. Vitamin D as well induced expression of cathelicidin, which was involved in the 
first line defense in patients with TB.  Single nucleotide polymorphisms in vitamin D 
receptor (VDR) gene have been associated with susceptibility to tuberculosis [40].  The 
genetic alterations of the VDR gene may lead to defects in gene activation or to changes in   
protein structure of the VDR, both of which could affect the cellular functions of 1,25-
dihydroxyvitamin D3. Various VDR polymorphisms could also be linked each other or to 
unidentified genes that were important determinants of disease risk [41]. Results of other 
study suggest that 1,25(OH)2D3 down regulates the production cytokines of pro-
inflammatory in addition to may control the exacerbated inflammatory response that may 
protect the host from excessive damage  of tissue at infection  site [42]. Epidemiological and 
experimental researches highlight that low level of the serum vitamin D was associated with 
impaired pulmonary function and it was potentially involved in a number of lung diseases. 
Moreover, a study of case-control in Ethiopia was determined the role of VDD as 
predisposing factor for pneumonia in children with age under 5 years [43]. There are  others 
studies on others vitamins in pulmonary TB patients such as a study of  [44] was found that 
The serum concentrations of vitamins A, D, and E were significantly lower in patients with 
tuberculosis than in control subjects . The net effect of 1,25(OH)2D3 to polarize T-helper 
responses toward a more regulatory Th2 phenotype, which was considered a key component 
of its capacity to suppress Th1-driven autoimmune responses. vitamin D deficiency  was 
impairs the ability of macrophages to mature, to producing specific surface antigens via 
down-regulating the membrane expression of major histocompatibility complex class II 
(MHC-II) molecules  to generate the lysosomal enzyme acid phosphatase and to secrete 
H2O2, essential tools for their antimicrobial function.  In contrast, the addition of VD3 
increases expression of macrophage-specific surface antigens and of lysosomal enzyme acid 
phosphatase  [40].The utilization of vitamin D for treatment of tuberculosis was common in 
the pre-antibiotic era [43]. 
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 الخلاصة
-LIو) γ-NFIلمرضى التدرن الرئوي من خلال تقدير مستويات الانترلوكينات  بعض معايير المناعة الخلويةتقييم  هدفت هذه الدراسة إلى
مريضا بالتدرن الرئوي من المراجعات الى العيادة الاستشارية  05من  تم خلال الدراسة جمع عينات الدم  3D .وتقدير فيتامين   21-LI (و01
ومن بين مرضى التدرن الرئوي، كان هناك . 7102إلى شباط  6102محافظة بابل خلال الفترة مابين شهر شباط -للأمراض الصدرية في الحلة 
 تركيزأظهر متوسط  .الاليزاباستخدام تقنية 3Dتم قياس السايتوكينات وفيتامين . عاما 08-21إناث، وعمر المرضى يتراوح بين  32ذكور و 72
) 940.1و 420.4( الرئوي بالمقارنة مع مجموعة السيطرة تدرن في مرضى ال) 50.0 ˂p(أن هناك زيادة معنوية  21-LIو  01-LIالدم  مصل
في مرضى ) 50.0˃p(زيادة معنوية  γ-NFI مصل تركيزفي حين لم يظهر متوسط .  مل على التوالي /بغ ) 415.31و 365.15( ,مل  /بغ 
 ˂ p(انخفاضا معنويا  3DV ل الدم مصل تركيزأظهر متوسط . مل /بغ ) 910.52و 505.63(التدرن الرئوي مقارنة بمجموعة السيطرة 
 .ل /نغ) 123.92و 681.81( بمجموعة السيطرةفي مرضى التدرن الرئوي مقارنة ) 50.0
 ، فحص الاليزا3، انترفيرون كاما، فيتامين دي)21،01(التدرن ، انترلوكين: دالةالكلمات ال
 
